Etanercept for the treatment of psoriasis and psoriatic arthritis

Dermatologic Therapy
Alice B Gottlieb

Abstract

Etanercept is a fully human soluble recombinant p75 TNF receptor that blocks the binding of TNF to cell surface receptors, thereby neutralizing its biologic activity. Data supporting the FDA's approval of etanercept for controlling signs and symptoms and for inhibiting XRAY progression of psoriatic arthritis will be presented. Data supporting the FDA filing of etanercept for the treatment of moderate to severe psoriasis will also be presented. Long term safety data of etanercept in the over 231,000 adults and children with rheumatoid arthritis who have been treated worldwide will be briefly summarized.

References

May 3, 1984·The New England Journal of Medicine·R S SternH L Bleich
Feb 1, 1995·The British Journal of Dermatology·A Y Finlay, E C Coles
Apr 1, 1994·Clinical and Experimental Immunology·P EttehadiR D Camp
Mar 1, 1993·Journal of the American Academy of Dermatology·H M SanderA Menter
Oct 1, 1995·International Journal of Dermatology·M A Gupta, A K Gupta
Sep 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L MellemkjaerJ H Olsen
Aug 25, 1999·Journal of the American Academy of Dermatology·S R RappD M Reboussin
Nov 4, 2000·Expert Opinion on Investigational Drugs·D D Gladman, J Brockbank
Jun 26, 2001·Journal of the American Academy of Dermatology·B KirbyC E Griffiths
Jan 5, 2002·Journal of the American Academy of Dermatology·James G Krueger
Aug 5, 2003·QJM : Monthly Journal of the Association of Physicians·R H Sterns, S M Silver
Nov 25, 2003·The New England Journal of Medicine·Craig L LeonardiUNKNOWN Etanercept Psoriasis Study Group
Dec 17, 2003·Archives of Dermatology·Alice B GottliebRalph Zitnik
Jul 13, 2004·Arthritis and Rheumatism·Philip J MeaseWayne Tsuji
Nov 1, 2006·The Ocular Surface·Gary D Novack

❮ Previous
Next ❯

Citations

Sep 1, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·G Wozel
Jun 30, 2009·Actas dermo-sifiliográficas·L PuigUNKNOWN Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología
Nov 1, 2005·Expert Opinion on Biological Therapy·Vicky Kwan Wong, Mark G Lebwohl
Oct 22, 2011·Journal of the American Academy of Dermatology·David M PariserScott W Baumgartner
Feb 27, 2009·The Journal of Investigative Dermatology·Honglin WangKarin Scharffetter-Kochanek
May 23, 2006·Journal of the American Academy of Dermatology·Clara De SimonePier Luigi Amerio
May 9, 2006·Clinical Therapeutics·Ulker GülHülya Gündüz
Nov 10, 2009·The Journal of Allergy and Clinical Immunology·Lisa C ZabaJames G Krueger
Jul 29, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jose L Sánchez CarazoVicente Oliver Martinez
May 12, 2007·American Journal of Clinical Dermatology·Alberto Romero-MatéSusana Córdoba-Guijarro
Jun 16, 2005·Current Opinion in Rheumatology·Philip J Mease
Sep 1, 2005·Expert Review of Clinical Immunology·Mathias Grunke, Joachim Robert Kalden
Aug 6, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alice B GottliebJames G Krueger
Jan 16, 2010·International Journal of Immunopathology and Pharmacology·G CaldarolaC Feliciani
May 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Asifa S HaiderJames G Krueger
Apr 21, 2009·Anais Brasileiros De Dermatologia·Ricardo RomitiMaria Denise Fonseca Takahashi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.